nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A2—Carmustine—malignant glioma	0.345	0.569	CbGbCtD
Albendazole—CYP3A4—Temozolomide—malignant glioma	0.26	0.43	CbGbCtD
Albendazole—TUBA1A—pons—malignant glioma	0.0287	0.211	CbGeAlD
Albendazole—TUBA1A—pineal body—malignant glioma	0.0205	0.151	CbGeAlD
Albendazole—TUBA1A—embryo—malignant glioma	0.00697	0.0514	CbGeAlD
Albendazole—TUBA1A—brainstem—malignant glioma	0.00639	0.0471	CbGeAlD
Albendazole—TUBA1A—retina—malignant glioma	0.00616	0.0454	CbGeAlD
Albendazole—Intracranial pressure increased—Carmustine—malignant glioma	0.00578	0.131	CcSEcCtD
Albendazole—TUBA1A—telencephalon—malignant glioma	0.00567	0.0418	CbGeAlD
Albendazole—TUBB4B—embryo—malignant glioma	0.00465	0.0342	CbGeAlD
Albendazole—TUBA1A—medulla oblongata—malignant glioma	0.00445	0.0328	CbGeAlD
Albendazole—TUBB4B—retina—malignant glioma	0.00411	0.0303	CbGeAlD
Albendazole—TUBA1A—midbrain—malignant glioma	0.00407	0.03	CbGeAlD
Albendazole—TUBA1A—spinal cord—malignant glioma	0.00397	0.0293	CbGeAlD
Albendazole—TUBB4B—telencephalon—malignant glioma	0.00378	0.0278	CbGeAlD
Albendazole—TUBA1A—central nervous system—malignant glioma	0.00322	0.0237	CbGeAlD
Albendazole—TUBA1A—cerebellum—malignant glioma	0.00315	0.0232	CbGeAlD
Albendazole—TUBB4B—medulla oblongata—malignant glioma	0.00297	0.0219	CbGeAlD
Albendazole—TUBB4B—midbrain—malignant glioma	0.00271	0.02	CbGeAlD
Albendazole—TUBB4B—spinal cord—malignant glioma	0.00265	0.0195	CbGeAlD
Albendazole—TUBA1A—brain—malignant glioma	0.00256	0.0188	CbGeAlD
Albendazole—ABCB1—blood vessel—malignant glioma	0.00227	0.0167	CbGeAlD
Albendazole—Aplastic anaemia—Temozolomide—malignant glioma	0.00219	0.0498	CcSEcCtD
Albendazole—TUBB4B—central nervous system—malignant glioma	0.00215	0.0158	CbGeAlD
Albendazole—TUBB4B—cerebellum—malignant glioma	0.0021	0.0155	CbGeAlD
Albendazole—TUBB4B—brain—malignant glioma	0.00171	0.0126	CbGeAlD
Albendazole—Liver function test abnormal—Carmustine—malignant glioma	0.00162	0.0368	CcSEcCtD
Albendazole—Pancytopenia—Carmustine—malignant glioma	0.00144	0.0327	CcSEcCtD
Albendazole—Neutropenia—Carmustine—malignant glioma	0.00142	0.0322	CcSEcCtD
Albendazole—Pancytopenia—Temozolomide—malignant glioma	0.00139	0.0316	CcSEcCtD
Albendazole—Neutropenia—Temozolomide—malignant glioma	0.00137	0.0311	CcSEcCtD
Albendazole—ABCB1—embryo—malignant glioma	0.00135	0.00996	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00129	0.0294	CcSEcCtD
Albendazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.00123	0.0281	CcSEcCtD
Albendazole—CYP1A1—central nervous system—malignant glioma	0.0012	0.00886	CbGeAlD
Albendazole—ABCB1—retina—malignant glioma	0.00119	0.0088	CbGeAlD
Albendazole—Hepatitis—Temozolomide—malignant glioma	0.00117	0.0267	CcSEcCtD
Albendazole—Urinary tract disorder—Temozolomide—malignant glioma	0.00116	0.0263	CcSEcCtD
Albendazole—Urethral disorder—Temozolomide—malignant glioma	0.00115	0.0261	CcSEcCtD
Albendazole—Erythema multiforme—Temozolomide—malignant glioma	0.00111	0.0252	CcSEcCtD
Albendazole—ABCB1—telencephalon—malignant glioma	0.0011	0.0081	CbGeAlD
Albendazole—Alopecia—Carmustine—malignant glioma	0.00107	0.0244	CcSEcCtD
Albendazole—Immune system disorder—Temozolomide—malignant glioma	0.00106	0.0241	CcSEcCtD
Albendazole—Alopecia—Temozolomide—malignant glioma	0.00104	0.0236	CcSEcCtD
Albendazole—CYP1A1—brain—malignant glioma	0.000955	0.00703	CbGeAlD
Albendazole—Leukopenia—Carmustine—malignant glioma	0.000945	0.0215	CcSEcCtD
Albendazole—Vertigo—Temozolomide—malignant glioma	0.000916	0.0208	CcSEcCtD
Albendazole—Leukopenia—Temozolomide—malignant glioma	0.000913	0.0208	CcSEcCtD
Albendazole—CYP3A4—central nervous system—malignant glioma	0.000882	0.0065	CbGeAlD
Albendazole—ABCB1—medulla oblongata—malignant glioma	0.000864	0.00636	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000862	0.0196	CcSEcCtD
Albendazole—Thrombocytopenia—Carmustine—malignant glioma	0.000843	0.0192	CcSEcCtD
Albendazole—Thrombocytopenia—Temozolomide—malignant glioma	0.000815	0.0185	CcSEcCtD
Albendazole—Skin disorder—Temozolomide—malignant glioma	0.000809	0.0184	CcSEcCtD
Albendazole—ABCB1—midbrain—malignant glioma	0.000789	0.00581	CbGeAlD
Albendazole—ABCB1—spinal cord—malignant glioma	0.00077	0.00567	CbGeAlD
Albendazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000704	0.016	CcSEcCtD
Albendazole—Body temperature increased—Carmustine—malignant glioma	0.000681	0.0155	CcSEcCtD
Albendazole—Abdominal pain—Carmustine—malignant glioma	0.000681	0.0155	CcSEcCtD
Albendazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000681	0.0155	CcSEcCtD
Albendazole—Urticaria—Temozolomide—malignant glioma	0.000661	0.015	CcSEcCtD
Albendazole—Body temperature increased—Temozolomide—malignant glioma	0.000658	0.015	CcSEcCtD
Albendazole—Abdominal pain—Temozolomide—malignant glioma	0.000658	0.015	CcSEcCtD
Albendazole—Hypersensitivity—Carmustine—malignant glioma	0.000635	0.0144	CcSEcCtD
Albendazole—ABCB1—central nervous system—malignant glioma	0.000625	0.0046	CbGeAlD
Albendazole—Hypersensitivity—Temozolomide—malignant glioma	0.000613	0.014	CcSEcCtD
Albendazole—ABCB1—cerebellum—malignant glioma	0.000611	0.0045	CbGeAlD
Albendazole—Dizziness—Carmustine—malignant glioma	0.00057	0.013	CcSEcCtD
Albendazole—Dizziness—Temozolomide—malignant glioma	0.000551	0.0125	CcSEcCtD
Albendazole—Vomiting—Carmustine—malignant glioma	0.000548	0.0125	CcSEcCtD
Albendazole—Rash—Carmustine—malignant glioma	0.000543	0.0124	CcSEcCtD
Albendazole—Dermatitis—Carmustine—malignant glioma	0.000543	0.0123	CcSEcCtD
Albendazole—Headache—Carmustine—malignant glioma	0.00054	0.0123	CcSEcCtD
Albendazole—Vomiting—Temozolomide—malignant glioma	0.000529	0.012	CcSEcCtD
Albendazole—Rash—Temozolomide—malignant glioma	0.000525	0.0119	CcSEcCtD
Albendazole—Dermatitis—Temozolomide—malignant glioma	0.000524	0.0119	CcSEcCtD
Albendazole—Headache—Temozolomide—malignant glioma	0.000522	0.0119	CcSEcCtD
Albendazole—Nausea—Carmustine—malignant glioma	0.000512	0.0116	CcSEcCtD
Albendazole—ABCB1—brain—malignant glioma	0.000496	0.00365	CbGeAlD
Albendazole—Nausea—Temozolomide—malignant glioma	0.000495	0.0112	CcSEcCtD
Albendazole—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.000247	0.00115	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000246	0.00114	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000246	0.00114	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00024	0.00111	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000233	0.00108	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000231	0.00107	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000228	0.00106	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000227	0.00105	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000224	0.00104	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.000218	0.00101	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000217	0.00101	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000217	0.00101	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.000215	0.000996	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—BCHE—malignant glioma	0.00021	0.000973	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000208	0.000968	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000208	0.000964	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000206	0.000958	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—FBXW7—malignant glioma	0.000206	0.000958	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000205	0.000953	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000202	0.000937	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000202	0.000937	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—F2—malignant glioma	0.000197	0.000915	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—BRCA2—malignant glioma	0.000196	0.000908	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000195	0.000904	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2B—malignant glioma	0.000194	0.0009	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000194	0.000899	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—RTEL1—malignant glioma	0.000193	0.000898	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000192	0.000892	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000192	0.000892	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTP1—malignant glioma	0.000191	0.000888	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000191	0.000887	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000191	0.000885	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00019	0.000882	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000189	0.00088	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000189	0.000879	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	0.000189	0.000876	CbGpPWpGaD
Albendazole—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000188	0.000874	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000188	0.000871	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000187	0.000869	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN2A—malignant glioma	0.000184	0.000853	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000181	0.000843	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	0.00018	0.000836	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MDM2—malignant glioma	0.000178	0.000827	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000176	0.000819	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000176	0.000817	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000173	0.000804	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00017	0.000788	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000169	0.000787	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000169	0.000784	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000168	0.000781	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000168	0.00078	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—BIRC5—malignant glioma	0.000167	0.000777	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP2—malignant glioma	0.000167	0.000776	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000166	0.000769	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000165	0.000766	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TERT—malignant glioma	0.000162	0.000753	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000157	0.000727	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—RTEL1—malignant glioma	0.000154	0.000717	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000154	0.000714	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000151	0.000703	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000148	0.000686	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000147	0.000684	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000145	0.000675	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000143	0.000664	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000143	0.000664	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—malignant glioma	0.000139	0.000646	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CXCL8—malignant glioma	0.000139	0.000644	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000138	0.000642	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000137	0.000638	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000137	0.000637	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000137	0.000636	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000137	0.000635	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000136	0.000632	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000136	0.000631	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000134	0.000623	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000134	0.000621	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000132	0.000611	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000129	0.000597	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000129	0.000597	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000127	0.000591	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—malignant glioma	0.000124	0.000578	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000124	0.000576	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000124	0.000574	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000123	0.000573	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000122	0.000569	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000122	0.000569	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000122	0.000566	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000122	0.000564	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000121	0.000564	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.00012	0.000558	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—F2—malignant glioma	0.000119	0.000552	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000116	0.000539	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—COX8A—malignant glioma	0.000111	0.000516	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—malignant glioma	0.000111	0.000515	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00011	0.000513	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MDM2—malignant glioma	0.000108	0.000499	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—malignant glioma	0.000102	0.000474	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP2—malignant glioma	0.000101	0.000468	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—malignant glioma	9.96e-05	0.000462	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.93e-05	0.000461	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	9.9e-05	0.00046	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—RAF1—malignant glioma	9.83e-05	0.000456	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	9.58e-05	0.000445	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—RTEL1—malignant glioma	9.52e-05	0.000442	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	9.47e-05	0.00044	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ASMT—malignant glioma	9.44e-05	0.000439	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	9.41e-05	0.000437	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	9.28e-05	0.000431	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.23e-05	0.000429	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BCAN—malignant glioma	8.88e-05	0.000412	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—COX8A—malignant glioma	8.87e-05	0.000412	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.81e-05	0.000409	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	8.56e-05	0.000397	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.53e-05	0.000396	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—malignant glioma	8.4e-05	0.00039	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—malignant glioma	8.38e-05	0.000389	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	8.07e-05	0.000375	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	7.66e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	7.55e-05	0.000351	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ASMT—malignant glioma	7.54e-05	0.00035	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	7.54e-05	0.00035	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	7.52e-05	0.000349	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—malignant glioma	7.51e-05	0.000349	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	7.44e-05	0.000346	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	7.28e-05	0.000338	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—IDH2—malignant glioma	7.16e-05	0.000332	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BCAN—malignant glioma	7.09e-05	0.000329	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—COX8A—malignant glioma	7.08e-05	0.000329	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.92e-05	0.000322	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.76e-05	0.000314	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.75e-05	0.000313	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2B6—malignant glioma	6.73e-05	0.000312	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.59e-05	0.000306	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	6.35e-05	0.000295	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.33e-05	0.000294	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—malignant glioma	6.17e-05	0.000287	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—IDH1—malignant glioma	6.15e-05	0.000286	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ASMT—malignant glioma	6.02e-05	0.00028	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SPHK1—malignant glioma	5.96e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.89e-05	0.000273	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2C18—malignant glioma	5.83e-05	0.000271	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.73e-05	0.000266	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—IDH2—malignant glioma	5.72e-05	0.000265	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BCAN—malignant glioma	5.66e-05	0.000263	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.5e-05	0.000255	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COX8A—malignant glioma	5.47e-05	0.000254	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2B6—malignant glioma	5.37e-05	0.00025	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5.27e-05	0.000245	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	5.16e-05	0.00024	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.01e-05	0.000233	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—IDH1—malignant glioma	4.92e-05	0.000228	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.91e-05	0.000228	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.87e-05	0.000226	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.84e-05	0.000225	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SPHK1—malignant glioma	4.76e-05	0.000221	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—malignant glioma	4.72e-05	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2C18—malignant glioma	4.66e-05	0.000216	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ASMT—malignant glioma	4.65e-05	0.000216	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH2—malignant glioma	4.56e-05	0.000212	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.48e-05	0.000208	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS1—malignant glioma	4.42e-05	0.000205	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.41e-05	0.000205	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BCAN—malignant glioma	4.37e-05	0.000203	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.33e-05	0.000201	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.3e-05	0.0002	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	4.29e-05	0.000199	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BCHE—malignant glioma	4.11e-05	0.000191	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC5A5—malignant glioma	4.06e-05	0.000189	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH1—malignant glioma	3.92e-05	0.000182	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.84e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.8e-05	0.000177	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SPHK1—malignant glioma	3.8e-05	0.000176	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—malignant glioma	3.77e-05	0.000175	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.72e-05	0.000173	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.66e-05	0.00017	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS1—malignant glioma	3.53e-05	0.000164	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH2—malignant glioma	3.52e-05	0.000164	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.51e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.32e-05	0.000154	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.31e-05	0.000154	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BCHE—malignant glioma	3.28e-05	0.000152	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—malignant glioma	3.27e-05	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC5A5—malignant glioma	3.24e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.2e-05	0.000148	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAT—malignant glioma	3.18e-05	0.000148	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.08e-05	0.000143	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH1—malignant glioma	3.03e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—malignant glioma	3.01e-05	0.00014	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOR1—malignant glioma	3.01e-05	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.99e-05	0.000139	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SPHK1—malignant glioma	2.93e-05	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.87e-05	0.000133	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS1—malignant glioma	2.82e-05	0.000131	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.81e-05	0.00013	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BCHE—malignant glioma	2.62e-05	0.000122	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—malignant glioma	2.61e-05	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.59e-05	0.00012	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAT—malignant glioma	2.54e-05	0.000118	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAV1—malignant glioma	2.45e-05	0.000114	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.45e-05	0.000114	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.43e-05	0.000113	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOR1—malignant glioma	2.4e-05	0.000111	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.34e-05	0.000109	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—malignant glioma	2.32e-05	0.000108	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.23e-05	0.000104	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS1—malignant glioma	2.18e-05	0.000101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—malignant glioma	2.15e-05	0.0001	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.12e-05	9.82e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—malignant glioma	2.09e-05	9.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAT—malignant glioma	2.03e-05	9.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BCHE—malignant glioma	2.02e-05	9.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	2e-05	9.28e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.96e-05	9.11e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAV1—malignant glioma	1.96e-05	9.09e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOR1—malignant glioma	1.92e-05	8.9e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—malignant glioma	1.78e-05	8.28e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—malignant glioma	1.72e-05	7.99e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.71e-05	7.94e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—malignant glioma	1.69e-05	7.87e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—malignant glioma	1.61e-05	7.47e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—malignant glioma	1.57e-05	7.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAT—malignant glioma	1.57e-05	7.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAV1—malignant glioma	1.56e-05	7.25e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.49e-05	6.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOR1—malignant glioma	1.48e-05	6.87e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—malignant glioma	1.48e-05	6.86e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.42e-05	6.61e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—malignant glioma	1.37e-05	6.38e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—malignant glioma	1.37e-05	6.34e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—malignant glioma	1.35e-05	6.28e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.25e-05	5.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAV1—malignant glioma	1.21e-05	5.6e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—malignant glioma	1.18e-05	5.48e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.1e-05	5.1e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.09e-05	5.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—malignant glioma	1.08e-05	5.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—malignant glioma	1.06e-05	4.92e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.04e-05	4.84e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.65e-06	4.48e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—malignant glioma	9.42e-06	4.38e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—malignant glioma	8.52e-06	3.95e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.41e-06	3.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—malignant glioma	8.34e-06	3.87e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—malignant glioma	8.33e-06	3.87e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—malignant glioma	7.27e-06	3.38e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—malignant glioma	6.8e-06	3.16e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	6.65e-06	3.09e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—malignant glioma	5.43e-06	2.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.13e-06	2.38e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—malignant glioma	4.19e-06	1.95e-05	CbGpPWpGaD
